Waystar (NASDAQ:WAY) Price Target Cut to $38.00 by Analysts at Bank of America

Key Points

• Bank of America cut its price target on Waystar to $38.00 (from $45) while retaining a "buy" rating, a target the report says implies roughly a 74.2% upside from the current stock price.
• Waystar's most recent quarter missed EPS expectations ($0.36 vs. $0.39) but revenue rose 24.3% year‑over‑year to $303.5 million, and the company set FY2026 guidance of $1.59–$1.68 in EPS.
• Analysts have a consensus rating of "Moderate Buy" with an average price target of $36.65, while the stock recently traded around $21.81 (down 3.7%), indicating a sizeable gap between price and consensus targets.

Waystar (NASDAQ:WAY - Get Free Report) had its target price lowered by equities researchers at Bank of America from $45.00 to $38.00 in a report released on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Bank of America's price target would indicate a potential upside of 74.23% from the stock's current price.

Other equities analysts also recently issued research reports about the stock. Jefferies Financial Group reissued a "buy" rating and set a $41.00 price target on shares of Waystar in a report on Wednesday, February 18th. TD Cowen reiterated a "buy" rating on shares of Waystar in a research report on Wednesday, February 18th. Canaccord Genuity Group reduced their target price on shares of Waystar from $54.00 to $30.00 and set a "buy" rating for the company in a research note on Wednesday, February 18th. Morgan Stanley started coverage on shares of Waystar in a research report on Monday, March 30th. They issued an "equal weight" rating and a $28.00 target price for the company. Finally, Freedom Capital raised Waystar from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 18th. Three investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $36.65.

Waystar Stock Down 3.7%

NASDAQ:WAY opened at $21.81 on Friday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.38. The stock has a 50 day moving average of $24.46 and a 200-day moving average of $31.11. The firm has a market capitalization of $4.18 billion, a PE ratio of 35.75, a price-to-earnings-growth ratio of 0.88 and a beta of 0.87. Waystar has a 52 week low of $21.09 and a 52 week high of $42.55.

Waystar (NASDAQ:WAY - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.03). Waystar had a return on equity of 6.86% and a net margin of 10.20%.The company had revenue of $303.54 million during the quarter, compared to the consensus estimate of $294.72 million. During the same period last year, the business posted $0.29 EPS. The company's revenue for the quarter was up 24.3% on a year-over-year basis. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Analysts predict that Waystar will post 0.39 EPS for the current year.

Insiders Place Their Bets

In related news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the company's stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total value of $1,209,968.00. Following the completion of the sale, the insider owned 474,826 shares of the company's stock, valued at $14,282,766.08. This represents a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 4.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in WAY. ANTIPODES PARTNERS Ltd raised its holdings in Waystar by 120.1% during the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company's stock worth $31,000 after purchasing an additional 449 shares in the last quarter. Kennedy Capital Management LLC increased its position in shares of Waystar by 0.5% during the 4th quarter. Kennedy Capital Management LLC now owns 106,207 shares of the company's stock valued at $3,478,000 after purchasing an additional 559 shares during the period. Pacer Advisors Inc. increased its position in shares of Waystar by 22.1% during the 4th quarter. Pacer Advisors Inc. now owns 3,144 shares of the company's stock valued at $103,000 after purchasing an additional 569 shares during the period. BCS Private Wealth Management Inc. raised its stake in shares of Waystar by 8.4% in the 3rd quarter. BCS Private Wealth Management Inc. now owns 7,455 shares of the company's stock worth $283,000 after buying an additional 575 shares in the last quarter. Finally, Carnegie Investment Counsel lifted its holdings in shares of Waystar by 9.4% in the third quarter. Carnegie Investment Counsel now owns 7,002 shares of the company's stock valued at $266,000 after buying an additional 600 shares during the period.

About Waystar

Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.